White Paper
Digital disease management for migraine
Read our white paper to learn how biopharma companies can use digital to support their migraine therapies.
Read Now
The central nervous system is amazingly complex, and that means that the conditions that involve the brain are also complicated to navigate—for patients and providers.
Digital health solutions, including real-time symptom tracking and comprehensive disease management tools, can make a world of difference in helping patients thrive while dealing with mental health challenges and neurological disorders.
CONDITIONS AND SYMPTOMS ARE COMPLEX
Trying to predict the speed of symptom acceleration for each individual patient can feel nearly impossible for providers. On top of that, they’re tasked with the challenge of matching evolving symptoms to the right drugs as new therapies come on the market.
WRAPAROUND SERVICES ARE CRITICAL–
YET NOT EASY TO ACCESS
There’s more to successfully treating mental health and neurological conditions than medication. Services like therapy and behavioral modifications are important, yet patients can’t always access the care they need, nor do so consistently.
LIMITED ACCESS TO SPECIALTY CARE
It can take months for new patients to get a first appointment with a specialist like a psychiatrist. Similarly, according to the American Academy of Neurology, patients waited an average of 30 business days for a follow-up visit with a neurologist.
TRIAL-AND-ERROR FOR
TREATMENT AND DOSING
Responses differ to commonly prescribed drugs for common mental health conditions like depression, anxiety and bipolar, or neurological disorders like MS, Parkinson’s and Alzheimer’s. It can take months of dosing and medication adjustments to find the right treatment.
I think there is a tremendous opportunity for digital in neurology. In one of my last posts I developed SaMD for measuring cognition levels. It is such a cool ability to be able to run through a series of tests very quickly within 10 minutes to measure cognition level, so that you might identify someone suffering from a dementia state.
Biopharma executive insight from market research
Explore the Platform
Patient-facing apps encourage symptom and QoL tracking. Algorithms use data from wearables and connected devices to track changes in physical symptoms, such as tremors in Parkinson’s patients, or to predict a mental health relapse.
With a provider dashboard at their fingertips, primary care providers have the individual patient data and population-level insights to make better treatment decisions.
Thoughtfully designed apps turn patients’ smartphones into digital companions, allowing for daily check-ins, support and motivation, and telehealth opportunities.
When patients can easily self-report symptoms and drug adherence from anywhere, providers have a better view of a patient’s overall condition between appointments.
Read our white paper to learn how biopharma companies can use digital to support their migraine therapies.
Read Now
Contact us today to start a conversation about how BrightInsight can help on your digital health journey.
Contact us